Formation of gold decorated porphyrin nanoparticles and evaluation of their photothermal and photodynamic activity.

A core-shell gold (Au) nanoparticle with improved photosensitization have been successfully fabricated using Au nanoparticles and 5,10,15,20 tetrakis pentafluorophenyl)-21H,23H-porphine (PF6) dye, forming a dyad through molecular self-assembly. Au nanoparticles were decorated on the shell and PF6 was placed in the core of the nanoparticles. Highly stable Au nanoparticles were achieved using PF6 with poly(N-vinylcaprolactam-co-N-vinylimidazole)-g-poly(D,L-lactide) graft copolymer hybridization. This was compared with hybridization using cetyltrimethylammonium bromide and polyethylene glycol-b-poly(D,L-lactide) for shell formation with PF6-Au. The resulting PF6-poly(N-vinylcaprolactam-co-N-vinylimidazole)-g-poly(D,L-lactide)-Au core-shell nanoparticle were utilized for photothermal and photodynamic activities. The spectroscopic analysis and zeta potential values of micelles revealed the presence of a thin Au layer coated on the PF6 nanoparticle surface, which generally enhanced the thermal stability of the gold nanoparticles and the photothermal effect of the shell. The core-shell PF6-Au nanoparticles were avidly taken up by cells and demonstrated cellular phototoxicity upon irradiation with 300W halogen lamps. The structural arrangement of PF6 dyes in the core-shell particles assures the effectiveness of singlet oxygen production. The study verifies that PF6 particles when companied with Au nanoparticles as PF6-Au have possible combinational applications in photodynamic and photothermal therapies for cancer cells because of their high production of singlet oxygen and heat.

Development of pH-sensitive pectinate/alginate microspheres for colon drug delivery.

The purposes of this study were to develop and evaluate calcium pectinate/alginate microspheres (PAMs) and to exploit their pH-sensitive properties for colon-targeted delivery of encapsulated cisplatin. PAMs were prepared using an electrospraying method. The PAMs, as cores, were then coated with Eudragit S100 using a polyelectrolyte multilayer coating technique in aqueous solution. The morphology of the microspheres was observed under scanning electron microscopy. In vitro drug release studies were performed in simulated gastrointestinal fluid, and the results indicated that approximately 5 % of the cisplatin was released from the Eudragit S100-coated PAMs, and 51 % of the cisplatin was released from the uncoated PAMs at 1 h. The release of cisplatin from the Eudragit S100-coated PAMs was more sustained in simulated gastric fluid than in simulated intestinal fluid due to the increased solubility of the coating polymer in media with pH >7.0. Drug release from the Eudragit S100-coated PAMs was best described by the Higuchi's square root model. From these results, it was concluded that Eudragit S100-coated PAMs are a potential carrier for delivery of cisplatin to the colon.